984 results match your criteria Medicinal Research Reviews[Journal]


Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Med Res Rev 2018 Dec 13. Epub 2018 Dec 13.

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.

In the last decade, cancer immunotherapy has emerged as an effective alternative to traditional therapies such as chemotherapy and radiation. In contrast to the latter, cancer immunotherapy has the potential to distinguish between cancer and healthy cells, and thus to avoid severe and intolerable side-effects, since the cancer cells are effectively eliminated by stimulated immune cells. The cytosolic nucleotide-binding oligomerization domains 1 and 2 receptors (NOD1 and NOD2) are important components of the innate immune system and constitute interesting targets in terms of strengthening the immune response against cancer cells. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/med.21557
Publisher Site
http://dx.doi.org/10.1002/med.21557DOI Listing
December 2018
1 Read

Evolution of efficacious pangenotypic hepatitis C virus therapies.

Med Res Rev 2018 Dec 2. Epub 2018 Dec 2.

Biomedical Informatics Research Laboratory, Department of Biology, Lahore University of Management Sciences, Lahore, Pakistan.

Hepatitis C compromises the quality of life of more than 350 million individuals worldwide. Over the last decade, therapeutic regimens for treating hepatitis C virus (HCV) infections have undergone rapid advancements. Initially, structure-based drug design was used to develop molecules that inhibit viral enzymes. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21554
Publisher Site
http://dx.doi.org/10.1002/med.21554DOI Listing
December 2018
4 Reads
8.431 Impact Factor

Design of Hedgehog pathway inhibitors for cancer treatment.

Med Res Rev 2018 Nov 28. Epub 2018 Nov 28.

Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska.

Hedgehog (Hh) signaling is involved in the initiation and progression of various cancers and is essential for embryonic and postnatal development. This pathway remains in the quiescent state in adult tissues but gets activated upon inflammation and injuries. Inhibition of Hh signaling pathway using natural and synthetic compounds has provided an attractive approach for treating cancer and inflammatory diseases. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21555
Publisher Site
http://dx.doi.org/10.1002/med.21555DOI Listing
November 2018
5 Reads

Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials.

Med Res Rev 2018 Nov 21. Epub 2018 Nov 21.

Division of Immunology, Biomedical Sciences Research Center "Alexander Fleming", Athens, Greece.

Several years after its isolation from melanoma cells, an increasing body of experimental evidence has established the involvement of Autotaxin (ATX) in the pathogenesis of several diseases. ATX, an extracellular enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) into the bioactive lipid lysophosphatidic acid (LPA), is overexpressed in a variety of human metastatic cancers and is strongly implicated in chronic inflammation and liver toxicity, fibrotic diseases, and thrombosis. Accordingly, the ATX-LPA signaling pathway is considered a tractable target for therapeutic intervention substantiated by the multitude of research campaigns that have been successful in identifying ATX inhibitors by both academia and industry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21551DOI Listing
November 2018
6 Reads

Topoisomerase 1B poisons: Over a half-century of drug leads, clinical candidates, and serendipitous discoveries.

Authors:
Maris A Cinelli

Med Res Rev 2018 Nov 19. Epub 2018 Nov 19.

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.

Topoisomerases are DNA processing enzymes that relieve supercoiling (torsional strain) in DNA, are necessary for normal cellular division, and act by nicking (and then religating) DNA strands. Type 1B topoisomerase (Top1) is overexpressed in certain tumors, and the enzyme has been extensively investigated as a target for cancer chemotherapy. Various chemical agents can act as "poisons" of the enzyme's religation step, leading to Top1-DNA lesions, DNA breakage, and eventual cellular death. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21546DOI Listing
November 2018
2 Reads

Recent clinical trends in Toll-like receptor targeting therapeutics.

Med Res Rev 2018 Nov 18. Epub 2018 Nov 18.

Department of Molecular Science and Technology, Ajou University, Suwon, Korea.

Toll-like receptors (TLRs) are germline-encoded receptors that are central to innate and adaptive immune responses. Owing to their vital role in inflammation, TLRs are rational targets in clinics; thus, many ligands and biologics have been reported to overcome the progression of various inflammatory and malignant conditions and support the immune system. For each TLR, at least one, and often many, drug formulations are being evaluated. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21553
Publisher Site
http://dx.doi.org/10.1002/med.21553DOI Listing
November 2018
5 Reads

Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Med Res Rev 2018 Nov 18. Epub 2018 Nov 18.

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

The concept of the high-affinity state postulates that a certain subset of G-protein-coupled receptors is primarily responsible for receptor signaling in the living brain. Assessing the abundance of this subset is thus potentially highly relevant for studies concerning the responses of neurotransmission to pharmacological or physiological stimuli and the dysregulation of neurotransmission in neurological or psychiatric disorders. The high-affinity state is preferentially recognized by agonists in vitro. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21552
Publisher Site
http://dx.doi.org/10.1002/med.21552DOI Listing
November 2018
3 Reads

Orexin supplementation in narcolepsy treatment: A review.

Med Res Rev 2018 Nov 14. Epub 2018 Nov 14.

Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.

Narcolepsy is a rare, chronic neurological disease characterized by excessive daytime sleepiness, cataplexy, vivid hallucinations, and sleep paralysis. Narcolepsy occurs in approximately 1 of 3000 people, affecting mainly adolescents aged 15 to 30 years. Recently, people with narcolepsy were shown to exhibit extensive orexin/hypocretin neuronal loss. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21550
Publisher Site
http://dx.doi.org/10.1002/med.21550DOI Listing
November 2018
11 Reads

Therapeutic strategies involving survivin inhibition in cancer.

Med Res Rev 2018 Nov 12. Epub 2018 Nov 12.

Department of Pathology and Experimental Therapeutics, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Survivin is a small protein that belongs to the inhibitor of apoptosis protein family. It is abundantly expressed in tumors compared with adult differentiated tissues, being associated with poor prognosis in many human neoplasms. This apoptotic inhibitor has a relevant role in both the promotion of cancer cell survival and in the inhibition of cell death. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21547
Publisher Site
http://dx.doi.org/10.1002/med.21547DOI Listing
November 2018
5 Reads

Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.

Med Res Rev 2018 Nov 11. Epub 2018 Nov 11.

Centre for Biosystems and Genome Network Medicine, Ioannina University, Ioannina, Greece.

Despite remarkable progress in medium-term overall survival benefit in the adjuvant, neoadjuvant and metastatic settings, with multiple recent targeted drug approvals, acquired resistance, late relapse, and cancer-related death rates remain challenging. Integrated technological systems have been developed to overcome these unmet needs. The characterization of structural and functional noncoding genome elements through next-generation sequencing (NGS) systems, Hi-C and CRISPR/Cas9, as well as computational models, allows for whole genome and transcriptome analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21549DOI Listing
November 2018

Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors.

Med Res Rev 2018 Nov 11. Epub 2018 Nov 11.

Laboratorio de Química Medicinal, Centro de Investigaciones en Bionanociencias (CIBION), CONICET, Ciudad de Buenos Aires, Argentina.

The type I human immunodeficiency virus (HIV-1) pandemic affecting over 37 million people worldwide continues, with 1.8 million people newly infected each year. Highly active antiretroviral therapy is efficient at reducing viral load and nearly one-half of the infected population is on treatment. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21544
Publisher Site
http://dx.doi.org/10.1002/med.21544DOI Listing
November 2018
4 Reads

Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target.

Med Res Rev 2018 Oct 25. Epub 2018 Oct 25.

Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.

Tubulin, the microtubules and their dynamic behavior are amongst the most successful antitumor, antifungal, antiparasitic, and herbicidal drug targets. Sulfonamides are exemplary drugs with applications in the clinic, in veterinary and in the agrochemical industry. This review summarizes the actual state and recent progress of both fields looking from the double point of view of the target and its drugs, with special focus onto the structural aspects. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21541DOI Listing
October 2018

Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era.

Med Res Rev 2018 Oct 24. Epub 2018 Oct 24.

Institute of Animal Nutrition, Department of Animal Nutrition, Northeast Agricultural University, Harbin, China.

Antimicrobial peptides (AMPs), critical components of the innate immune system, are widely distributed throughout the animal and plant kingdoms. They can protect against a broad array of infection-causing agents, such as bacteria, fungi, parasites, viruses, and tumor cells, and also exhibit immunomodulatory activity. AMPs exert antimicrobial activities primarily through mechanisms involving membrane disruption, so they have a lower likelihood of inducing drug resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21542DOI Listing
October 2018

Therapeutic potential of pteridine derivatives: A comprehensive review.

Med Res Rev 2018 Oct 19. Epub 2018 Oct 19.

Departamento de Bioquímica, Biología Molecular (B) e Inmunología, Facultad de Medicina, IMIB and Regional Campus of International Excellence "Campus Mare Nostrum," Universidad de Murcia, Murcia, Spain.

Pteridines are aromatic compounds formed by fused pyrazine and pyrimidine rings. Many living organisms synthesize pteridines, where they act as pigments, enzymatic cofactors, or immune system activation molecules. This variety of biological functions has motivated the synthesis of a huge number of pteridine derivatives with the aim of studying their therapeutic potential. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21529DOI Listing
October 2018
1 Read

Lipidic prodrug approach for improved oral drug delivery and therapy.

Med Res Rev 2018 Oct 15. Epub 2018 Oct 15.

Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

In the past, a prodrug design was used as a last option to improve bioavailability through controlling transport, distribution, metabolism, or other mechanisms. Prodrugs are currently used even in early stages of drug development, and a significant percentage of all drugs in the market are prodrugs. The focus of this article is lipidic prodrugs, a strategy whereby a lipid carrier is covalently bound to the drug moiety. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21533
Publisher Site
http://dx.doi.org/10.1002/med.21533DOI Listing
October 2018
7 Reads

Recent structural advances in constrained helical peptides.

Med Res Rev 2018 Oct 11. Epub 2018 Oct 11.

Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois.

Given the ubiquity of the ⍺-helix in the proteome, there has been much research in developing mimics of ⍺-helices, and most of this study has been toward developing protein-protein interaction inhibitors. A common strategy for mimicking ⍺-helices has been through the use of constrained, helical peptides. The addition of a constraint typically provides for conformational and proteolytic stability and, in some cases, cell permeability. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21540
Publisher Site
http://dx.doi.org/10.1002/med.21540DOI Listing
October 2018
1 Read

The multifaceted role of autophagy in cancer and the microenvironment.

Med Res Rev 2018 Oct 9. Epub 2018 Oct 9.

Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Autophagy is a crucial recycling process that is increasingly being recognized as an important factor in cancer initiation, cancer (stem) cell maintenance as well as the development of resistance to cancer therapy in both solid and hematological malignancies. Furthermore, it is being recognized that autophagy also plays a crucial and sometimes opposing role in the complex cancer microenvironment. For instance, autophagy in stromal cells such as fibroblasts contributes to tumorigenesis by generating and supplying nutrients to cancerous cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21531DOI Listing
October 2018

Roles of microRNAs in T cell immunity: Implications for strategy development against infectious diseases.

Med Res Rev 2018 Sep 11. Epub 2018 Sep 11.

Key Laboratory of Animal Parasitology of Ministry of Agriculture, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.

T cell immunity plays a vital role in pathogen infections. MicroRNA (miRNAs) are small, single-stranded noncoding RNAs that regulate T cell immunity by targeting key transcriptional factors, signaling proteins, and cytokines associated with T cell activation, differentiation, and function. The dysregulation of miRNA expression in T cells may lead to specific immune responses and can provide new therapeutic opportunities against various infectious diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21539DOI Listing
September 2018

Involvement of calpain in the neuropathogenesis of Alzheimer's disease.

Med Res Rev 2018 Sep 10. Epub 2018 Sep 10.

Department of Pathophysiology, Key Laboratory of Education Ministry of China for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Alzheimer's disease (AD) is the most common (60% to 80%) age-related disease associated with dementia and is characterized by a deterioration of behavioral and cognitive capacities leading to death in few years after diagnosis, mainly due to complications from chronic illness. The characteristic hallmarks of the disease are extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs) with neuropil threads, which are a direct result of amyloid precursor protein (APP) processing to Aβ, and τ hyperphosphorylation. However, many indirect underlying processes play a role in this event. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21534DOI Listing
September 2018
2 Reads

Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors.

Med Res Rev 2018 Sep 24. Epub 2018 Sep 24.

Center for Biomaterials, Korea Institute of Science and Technology, Seoul, Korea.

The mechanistic/mammalian target of rapamycin (mTOR), also known as the mechanistic target of rapamycin, regulates many normal cell processes such as transcription, cell growth, and autophagy. Overstimulation of mTOR by its ligands, amino acids, sugars, and/or growth factors leads to physiological disorders, including cancer and neurodegenerative diseases. In this study, we reviewed the recent advances regarding the mechanism that involves mTOR in cancer, aging, and neurodegenerative diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21535DOI Listing
September 2018

Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules.

Med Res Rev 2019 01 14;39(1):265-301. Epub 2018 Sep 14.

Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.

Cancer immunotherapy has made great strides in the recent decade, especially in the area of immune checkpoint blockade. The outstanding efficacy, prolonged durability of effect, and rapid assimilation of anti-PD-1 and anti-PD-L1 monoclonal antibodies in clinical practice have been nothing short of a medical breakthrough in the treatment of numerous malignancies. The major advantages of these therapeutic antibodies over their small molecule counterparts have been their high binding affinity and target specificity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21530DOI Listing
January 2019

Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.

Med Res Rev 2018 Sep 7. Epub 2018 Sep 7.

Center for the Study of Systems Biology, School of Biology, Georgia Institute of Technology, Atlanta, Georgia.

Escherichia coli Dihydrofolate reductase is an important enzyme that is essential for the survival of the Gram-negative microorganism. Inhibitors designed against this enzyme have demonstrated application as antibiotics. However, either because of poor bioavailability of the small-molecules resulting from their inability to cross the double membrane in Gram-negative bacteria or because the microorganism develops resistance to the antibiotics by mutating the DHFR target, discovery of new antibiotics against the enzyme is mandatory to overcome drug-resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21538DOI Listing
September 2018
8.430 Impact Factor

Polyphenolic natural products and natural product-inspired steroidal mimics as aromatase inhibitors.

Med Res Rev 2018 Sep 1. Epub 2018 Sep 1.

Department of Chemistry & Chemical Biology, McMaster University, Hamilton, Ontario, Canada.

The discovery of biologically active polyphenolic natural products, including chalcones, stilbenes, flavanones, and isoflavones as steroidal mimics has proven to be a subject of considerable importance in medicine. Some of these natural compounds have been shown to modulate key human metabolic processes via steroidal hormone receptors, or to inhibit crucial enzymes involved in the biosynthesis of steroidal hormones themselves. Isoflavone polyphenolics such as genistein are well known for this "phytoestrogenic" biological activity. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21536
Publisher Site
http://dx.doi.org/10.1002/med.21536DOI Listing
September 2018
2 Reads

Progress in the application of CRISPR: From gene to base editing.

Med Res Rev 2018 Sep 1. Epub 2018 Sep 1.

Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts.

The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated endonucleases (Cas) has been utilized for genome editing with great accuracy and high efficiency in generating gene knockout, knockin, and point mutations in eukaryotic genomes. However, traditional CRISPR/Cas9 technology introduces double-stranded DNA breaks (DSBs) at a target locus as the first step to make gene corrections, which easily results in undesired mutations. Thus, it is necessary to develop new methods for correcting the unwanted mutations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21537DOI Listing
September 2018
9 Reads

Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.

Med Res Rev 2018 Aug 22. Epub 2018 Aug 22.

Department of Pharmacy, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.

Kidney diseases have become a global public health problem. The application of kidney-targeted drug-delivery systems in the management of kidney diseases has profound transformative potential. Kidney-targeted drug delivery can reduce the undesired side effects of often potent drugs and enhance drug efficacy in alleviating the kidney disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21532DOI Listing
August 2018
1 Read

Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.

Med Res Rev 2018 Aug 12. Epub 2018 Aug 12.

Center of Physiology, Georg-August University, Goettingen, Germany.

Over the past decades, a multitude of experimental drugs have been shown to delay disease progression in preclinical animal models of amyotrophic lateral sclerosis (ALS) but failed to show efficacy in human clinical trials or are still waiting for approval under Phase I-III trials. Riluzole, a glutamatergic neurotransmission inhibitor, is the only drug approved by the USA Food and Drug Administration for ALS treatment with modest benefits on survival. Recently, an antioxidant drug, edaravone, developed by Mitsubishi Tanabe Pharma was found to be effective in halting ALS progression during early stages. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21528
Publisher Site
http://dx.doi.org/10.1002/med.21528DOI Listing
August 2018
36 Reads

Erythropoiesis and chronic kidney disease-related anemia: From physiology to new therapeutic advancements.

Med Res Rev 2018 Aug 6. Epub 2018 Aug 6.

Chair of Nephrology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Erythropoiesis is triggered by hypoxia and is strictly regulated by hormones, growth factors, cytokines, and vitamins to ensure an adequate oxygen delivery to all body cells. Abnormalities in one or more of these factors may induce different kinds of anemia requiring different treatments. A key player in red blood cell production is erythropoietin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21527DOI Listing
August 2018
8.431 Impact Factor

Protein-protein interactions as antibiotic targets: A medicinal chemistry perspective.

Med Res Rev 2018 Jul 13. Epub 2018 Jul 13.

Discipline of Chemistry, School of Environmental & Life Sciences, The University of Newcastle, Callaghan, Australia.

There are 27 small molecule protein-protein interaction (PPI) modulators in Phase I, II, and III clinical trials targeting cancer, viruses, autoimmune disorders, and as immune suppression agents. Targeting PPIs as an antibiotic drug discovery strategy remains in relative infancy by comparison. However, a number of molecules are in development which target PPI within the replisome, divisome, transcriptome, and translatome are showing significant promise at the medicinal chemistry stage of drug development. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21519DOI Listing
July 2018
10 Reads

Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes.

Med Res Rev 2019 01 27;39(1):349-385. Epub 2018 Jun 27.

Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.

Serine/threonine kinases (STKs) represent the majority of discovered kinases to date even though a few Food and Drug Administration approved STKs inhibitors are reported. The third millennium came with the discovery of an important group of STKs that reshaped our understanding of several biological signaling pathways. This family was named death-associated protein kinase family (DAPK family). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21518DOI Listing
January 2019
1 Read

New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs.

Med Res Rev 2018 09 7;38(5):1674-1705. Epub 2018 Jun 7.

School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China.

Pathological angiogenesis plays a crucial role in malignant neoplasia. Vascular normalization has been confirmed as a promising strategy to promote chemotherapy efficacy. However, compensatory activation of alternative angiogenic receptor tyrosine kinases (RTKs) reduces vascular normalization and induces resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21517DOI Listing
September 2018

Complex roles of the old drug aspirin in cancer chemoprevention and therapy.

Med Res Rev 2019 01 1;39(1):114-145. Epub 2018 Jun 1.

Collaborative Innovation Center of Biotherapy, Chengdu, China.

The nonsteroidal anti-inflammatory agent aspirin is widely used for preventing and treating cardiovascular and cerebrovascular diseases. In addition, epidemiologic evidences reveal that aspirin may prevent a variety of human cancers, while data on the association between aspirin and some kinds of cancer are conflicting. Preclinical studies and clinical trials also reveal the therapeutic effect of aspirin on cancer. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21514
Publisher Site
http://dx.doi.org/10.1002/med.21514DOI Listing
January 2019
7 Reads

Selective targeting of antiapoptotic BCL-2 proteins in cancer.

Med Res Rev 2019 01 30;39(1):146-175. Epub 2018 May 30.

Department of Medical Genetics, Adana Medical and Research Center, School of Medicine, Baskent University, Yuregir, Adana, Turkey.

Circumvention of apoptotic machinery is one of the distinctive properties of carcinogenesis. Extensively established key effectors of such apoptotic bypass mechanisms, the antiapoptotic BCL-2 (apoptosis regulator BCL-2) proteins, determine the response of cancer cells to chemotherapeutics. Within this background, research and development of antiapoptotic BCL-2 inhibitors were considered to have a tremendous amount of potential toward the discovery of novel pharmacological modulators in cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21516DOI Listing
January 2019
13 Reads

Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.

Med Res Rev 2018 09 30;38(6):2110-2136. Epub 2018 May 30.

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

Nanotechnology as an emerging field has established inevitable impacts on nano-biomedicine and treatment of formidable diseases, inflammations, and malignancies. In this regard, substantial advances in the design of systems for delivery of therapeutic agents have emerged magnificent and innovative pathways in biomedical applications. Chitosan (CS) is derived via deacetylation of chitin as the second most abundant polysaccharide. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21506DOI Listing
September 2018

Progress and challenges in the prevention and control of nonalcoholic fatty liver disease.

Med Res Rev 2019 01 30;39(1):328-348. Epub 2018 May 30.

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. Individuals with NAFLD have a high frequency of developing progressive liver disease and metabolism-related comorbidities, which result from of a lack of awareness and poor surveillance of the disease and a paucity of approved and effective therapies. Managing the complications of NAFLD has already begun to place a tremendous burden on health-care systems. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21515DOI Listing
January 2019
8.431 Impact Factor

Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances.

Med Res Rev 2019 01 29;39(1):176-264. Epub 2018 May 29.

Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.

Multidrug resistance-associated protein 1 (MRP1, ABCC1) is an ATP-binding cassette (ABC) transport protein. This efflux pump uses the energy of ATP hydrolysis to export structurally diverse antineoplastic agents in human cancers. The upregulation of MRP1 (either inherent or acquired) is one major reason for the occurrence of the phenomenon called multidrug resistance (MDR). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21510DOI Listing
January 2019

Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection.

Med Res Rev 2019 01 28;39(1):404-422. Epub 2018 May 28.

Department of Chemistry, Faculty of Medicine, University of Nis, Bulevar Dr Zorana Djindjica 81, 18000 Nis, Serbia.

Dipeptidyl peptidase-4 (DPP-4) cleaves N-terminal dipeptides, with Pro, Ala or Ser at the penultimate position, and, in that way, modulates biological activity of certain polypeptides. Due to its ubiquitous distribution, many pathological processes are associated with altered DPP-4 expression and activity. Besides the regulation of glucose metabolism, DPP-4 also exhibits many other systemic effects, and the inhibition of its activity might lead to cardiovascular and renal protection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21513DOI Listing
January 2019
1 Read

Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment.

Med Res Rev 2019 01 22;39(1):386-403. Epub 2018 May 22.

Henan Medical Key Laboratory of Translational Research on Psychiatric Diseases, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.

Although antipsychotic drugs are mainly used for treating schizophrenia, they are widely used for treating various psychiatric diseases in adults, the elderly, adolescents and even children. Today, about 1.2% of the worldwide population suffers from psychosis and related disorders, which translates to about 7. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21512DOI Listing
January 2019
8 Reads

Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target.

Med Res Rev 2019 01 22;39(1):70-113. Epub 2018 May 22.

Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Andalucía Tech, Universidad de Málaga, Málaga, Spain.

Since reprogramming energy metabolism is considered a new hallmark of cancer, tumor metabolism is again in the spotlight of cancer research. Many studies have been carried out and many possible therapies have been developed in the last years. However, tumor cells are not alone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21511DOI Listing
January 2019
2 Reads

Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy.

Med Res Rev 2019 01 17;39(1):40-69. Epub 2018 May 17.

Department for Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.

The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic strategies. Prostate tumors specifically express the prostate-specific membrane antigen (PSMA), a membrane-bound protease. As PSMA is highly overexpressed on malignant prostate tumor cells and as its expression rate correlates with the aggressiveness of the disease, this tumor-associated biomarker provides the possibility to develop new strategies for diagnostics and therapy of PCa. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21508DOI Listing
January 2019
4 Reads

Gold nanoparticles in ophthalmology.

Med Res Rev 2019 01 16;39(1):302-327. Epub 2018 May 16.

CUO-Recherche, Hôpital du Saint-Sacrement, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, Université Laval, Quebec, Canada.

Many research projects are underway to improve the diagnosis and therapy in ophthalmology. Indeed, visual acuity deficits affect 285 million people worldwide and different strategies are being developed to strengthen patient care. One of these strategies is the use of gold nanoparticles (GNP) for their multiple properties and their ability to be used as both diagnosis and therapy tools. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21509DOI Listing
January 2019

The underlying pathophysiology and therapeutic approaches for osteoporosis.

Med Res Rev 2018 09 7;38(6):2024-2057. Epub 2018 May 7.

Medicinal Chemistry Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.

With an increase in the ageing population worldwide, the prevalence of osteoporosis increases at an alarming rate in both male and female irrespective of their ethnicity. At present, the currently available therapeutic options are mostly limited to either bone resorptive or bone forming efficacies and both approaches are associated with serious side effects. Despite these options, there is still need for newer therapeutics to treat osteoporosis, which can offer beneficial effects for maintaining balanced dynamics between bone formation and bone resorption, devoid of any side effect. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21504DOI Listing
September 2018

Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer.

Med Res Rev 2018 09 7;38(6):2058-2109. Epub 2018 May 7.

Faculty of Pharmacy, Pharmaceutical Chemistry Department, Ain Shams University, Abbassia, Cairo, Egypt.

Recently, molecular hybridization paradigm became an interesting and smart way to defeat the multifaceted cancer disease by a single molecular entity that acts via several mechanisms just like a magic bullet. Also, HDAC is an important epigenetic target in drug discovery, and the HDAC inhibitors showed successful pattern as cytotoxic agents. Because of their flexible structure activity relationship, it was easy to link them to other anticancer scaffolds. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21505DOI Listing
September 2018
2 Reads

Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update.

Med Res Rev 2019 01 4;39(1):5-39. Epub 2018 May 4.

State Key Laboratory of Applied Organic Chemistry and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.

Mammalian thioredoxin reductase (TrxR) enzymes are homodimeric flavin proteins sharing a unique yet essential selenocysteine residue at their C-terminus. TrxRs, together with their endogenous substrate thioredoxins, play a crucial role in regulating diverse cellular redox events. A wealth of evidence from both clinic observations and bench studies supports that overactivation/dysfunction of TrxRs has a close link to the onset and development of various diseases, such as cancer and neurodegeneration. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21507DOI Listing
January 2019

Recent advances in the discovery and development of factor XI/XIa inhibitors.

Med Res Rev 2018 09 4;38(6):1974-2023. Epub 2018 May 4.

Department of Medicinal Chemistry, and Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.

Factor XIa (FXIa) is a serine protease homodimer that belongs to the intrinsic coagulation pathway. FXIa primarily catalyzes factor IX activation to factor IXa, which subsequently activates factor X to factor Xa in the common coagulation pathway. Growing evidence suggests that FXIa plays an important role in thrombosis with a relatively limited contribution to hemostasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173998PMC
September 2018
2 Reads

Proteasome-mediated proteostasis: Novel medicinal and pharmacological strategies for diseases.

Med Res Rev 2018 09 2;38(6):1916-1973. Epub 2018 May 2.

Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.

Proteins actively participate in a wide range of cellular physiological functions. But aggregation of proteins results in cytotoxicity, and unwanted aggregation of misfolded proteins often causes many diseases. During abnormal protein aggregation events, cells try to cope against such deleterious consequences because of the remarkable functional attempts of two distinct proteolytic mechanisms. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21502
Publisher Site
http://dx.doi.org/10.1002/med.21502DOI Listing
September 2018
3 Reads

Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening.

Med Res Rev 2018 09 16;38(6):1874-1915. Epub 2018 Apr 16.

Research Group in Cheminformatics & Nutrition, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Spain.

The inhibition of dipeptidyl peptidase-IV (DPP-IV) has emerged over the last decade as one of the most effective treatments for type 2 diabetes mellitus, and consequently (a) 11 DPP-IV inhibitors have been on the market since 2006 (three in 2015), and (b) 74 noncovalent complexes involving human DPP-IV and drug-like inhibitors are available at the Protein Data Bank (PDB). The present review aims to (a) explain the most important activity cliffs for DPP-IV noncovalent inhibition according to the binding site structure of DPP-IV, (b) explain the most important selectivity cliffs for DPP-IV noncovalent inhibition in comparison with other related enzymes (i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21499DOI Listing
September 2018
33 Reads

In honor of Professor Li-He Zhang on the occasion of his 80th birthday.

Med Res Rev 2018 05;38(3):773-774

Associate Professor of Chemistry, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21500DOI Listing
May 2018
4 Reads

Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds.

Med Res Rev 2018 09 10;38(6):1837-1873. Epub 2018 Apr 10.

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Newly developed protein drugs that target tumor-associated antigens are often modified in order to increase their therapeutic effect, tumor exposure, and safety profile. During the development of protein drugs, molecular imaging is increasingly used to provide additional information on their in vivo behavior. As a result, there are increasing numbers of studies that demonstrate the effect of protein modification on whole body distribution and tumor uptake of protein drugs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21498DOI Listing
September 2018
2 Reads

Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one.

Med Res Rev 2018 09 10;38(6):1799-1836. Epub 2018 Apr 10.

Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy.

Human carbonic anhydrase (CA) IX is a tumor-associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state-of-the-art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21497DOI Listing
September 2018
3 Reads

Avenues to molecular imaging of dying cells: Focus on cancer.

Med Res Rev 2018 09 12;38(6):1713-1768. Epub 2018 Mar 12.

Molecular Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Successful treatment of cancer patients requires balancing of the dose, timing, and type of therapeutic regimen. Detection of increased cell death may serve as a predictor of the eventual therapeutic success. Imaging of cell death may thus lead to early identification of treatment responders and nonresponders, and to "patient-tailored therapy. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/med.21495
Publisher Site
http://dx.doi.org/10.1002/med.21495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220832PMC
September 2018
15 Reads